PointState Capital’s GenMark Diagnostics, Inc GNMK Stock Holding History

PointState Capital’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-200,000	Closed	-$2.36M	–	180
2016 Q3	$2.36M	Buy	+200,000	New	+$1.93M	0.02%	126
2014 Q1	–	Sell	-298,976	Closed	-$3.97M	–	161
2013 Q4	$3.97M	Hold	298,976	–	–	0.05%	122
2013 Q3	$3.63M	Hold	298,976	–	–	0.06%	113
2013 Q2	$3.09M	Buy	+298,976	New	+$4.12M	0.05%	117

Other funds holding GNMK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PointState Capital's GNMK Position: Q4 2016 in Review

PointState Capital sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2016, closing a stake of 200,000 shares — an estimated $2.36M sold.

PointState Capital first reported a position in GNMK in Q2 2013 and held it in 4 quarters. The position peaked at $3.97M in Q4 2013. 90 funds tracked by Wall St. Rank hold GNMK as of Q4 2016.

PointState Capital reported no remaining GenMark Diagnostics, Inc position as of Q4 2016 after selling out during the quarter.
PointState Capital sold 200,000 GenMark Diagnostics, Inc shares in Q4 2016, an estimated $2.36M.
PointState Capital first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 4 quarters.
PointState Capital's GenMark Diagnostics, Inc position peaked at $3.97M in Q4 2013.
90 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2016.

Based on PointState Capital's 13F filing for Q4 2016, filed 14 Feb 2017.